GL-V9 (5-hydroxy-8-methoxy-2-phenyl-7-(4-(pyrrolidin-1-yl)butoxy)4 H-chromen-4-one) is a synthesized flavonoid with strong anti-inflammatory and anti-tumor activities that is able to modulate the signaling pathway associated with the NLRP3 inflammasome. Here, NLRP3 is linked to neoplasm.